The estimated Net Worth of James A. Jr. Robinson is at least $7.19 Tausend dollars as of 4 April 2019. Mr. Robinson owns over 6,250 units of Neos Therapeutics Inc stock worth over $7,188 and over the last 7 years he sold NEOS stock worth over $0. In addition, he makes $0 as Independent Director at Neos Therapeutics Inc.
Sign up
Mr. Robinson NEOS stock SEC Form 4 insiders trading
James has made over 1 trades of the Neos Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 6,250 units of NEOS stock worth $7,188 on 4 April 2019.
The largest trade he's ever made was exercising 6,250 units of Neos Therapeutics Inc stock on 4 April 2019 worth over $7,188. On average, James trades about 347 units every 0 days since 2018. As of 4 April 2019 he still owns at least 6,250 units of Neos Therapeutics Inc stock.
You can see the complete history of Mr. Robinson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
James Robinson biography
James A. Robinson serves as Independent Director of the Company. Mr. Robinson currently serves as the President and Chief Operating Officer of Alkermes, where he leads the commercial, operations, business development, and human resources functions. Prior to joining Alkermes, he joined Astellas in 2005 as vice president of health systems, rising to President of Astellas Americas Operations in 2016. Prior to joining Astellas, he served as an executive at the former Schering-Plough Corporation, which was acquired by Merck & Company in 2009. Mr. Robinson is a member of The Commercial Club of Chicago and serves on the BioScience Council for ChicagoNEXT. He is a founding member of MATTER and is also on the Board of Directors for the Chicago Botanic Garden. Mr. Robinson received his Bachelor of Science degree from DePaul University.
How old is James Robinson?
James Robinson is 50, he's been the Independent Director of Neos Therapeutics Inc since 2019. There are 7 older and 1 younger executives at Neos Therapeutics Inc. The oldest executive at Neos Therapeutics Inc is Alan Heller, 66, who is the Independent Chairman of the Board.
What's James Robinson's mailing address?
James's mailing address filed with the SEC is 400 ALEXANDER PARK DRIVE, , PRINCETON, NJ, 08540.
Insiders trading at Neos Therapeutics Inc
Over the last 9 years, insiders at Neos Therapeutics Inc have traded over $796,275 worth of Neos Therapeutics Inc stock and bought 558,630 units worth $7,201,055 . The most active insiders traders include Jack W Schuler, James E Deerfield Mgmt L.P.... und Bryant Fong. On average, Neos Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $42,698. The most recent stock trade was executed by Richard I Eisenstadt on 12 December 2018, trading 5,000 units of NEOS stock currently worth $10,800.
What does Neos Therapeutics Inc's logo look like?
Complete history of Mr. Robinson stock trades at Alkermes plc, Applied Genetic Technologies Corp, Neos Therapeutics Inc, UroGen Pharma Ltd und Urovant Sciences Ltd
Neos Therapeutics Inc executives and stock owners
Neos Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Gerald McLaughlin,
President, Chief Executive Officer, Director -
Richard Eisenstadt,
Chief Financial Officer, Treasurer -
John Limongelli,
Senior Vice President, General Counsel and Corporate Secretary -
Alan Heller,
Independent Chairman of the Board -
Linda Szyper,
Independent Director -
John Schmid,
Independent Director -
Gregory Robitaille,
Independent Director -
Bryant Fong,
Independent Director -
James Robinson,
Independent Director -
Beth Hecht,
Independent Director -
Vipin K Garg,
President, CEO & Director -
Juergen Martens,
Chief Tech/Operations Officer -
Thomas P Mc Donnell,
Chief Commercial Officer -
Paul R Edick,
Director -
Partners 2007, L.P.Presidio...,
-
Dorothy Engelking,
VP of Regulatory Affairs -
Mark Tengler,
Chief Technology Officer -
Ralph Essex Capital Corp Ia...,
-
Andrew G Delaware Street Ca...,
-
Jack W Schuler,
10% owner -
Venture Assoicates Ii Llcbu...,
-
James E Deerfield Mgmt L.P....,